Emil Pharmaceutical Industries Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1986.
1986 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Emil Pharmaceutical Industries Private Limited

Emil Pharmaceutical Industries Private Limited, a active private limited company, was established on 13 May 1986 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1986PTC039809. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹34.15 Cr and a paid-up capital of ₹21.33 Cr.

It upholds a compliant status. Employing 81 professional, Its leadership includes Manjiri Anil Devdhar (Director), Abhijit Rajendra Gole (Director), Mayur Anand Sirdesai (Director). Past directors included Prakash Chimanlal Mistry, Abhijit Rajendra Gole, Mayur Anand Sirdesai. It holds ₹213.00 Cr open charges and ₹88.46 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 101 Mangalamkulupwadi Borivali E, Mumbai, Maharashtra, 400066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1986PTC039809

  • Registration Number

    039809

  • Incorporation Date

    13 May 1986

  • Authorized Capital

    ₹34.15 Cr

  • Paid-Up Capital

    ₹21.33 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 34.15 Cr
  • Paid Up Capital ₹ 21.33 Cr
  • Company Age 39 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 213.00 Cr
  • Satisfied Charges ₹ 88.46 Cr
  • Revenue Growth **** 27.54%
  • Profit Growth **** -36.19%
  • Ebitda **** -17.38%
  • Net Worth 138.92%
  • Total Assets **** 193.59%
Company report

Emil Pharmaceutical Industries Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Emil Pharmaceutical Industries Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Emil Pharmaceutical Industries Private Limited?
Current Directors
Name Designation Appointment Date Status
Manjiri Anil Devdhar Director 24 Feb 2004 Current
Abhijit Rajendra Gole Director 19 Aug 2024 Current
Mayur Anand Sirdesai Director 17 Apr 2023 Current
Sumegha Sanjiv Patange Director 24 Feb 2004 Current
Tushar Anil Korday Director 13 May 1986 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Chief Financial Officer - Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 17 Apr 2023 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 22 Sep 2004 Past
Pramod Abcsdd Director 16 Aug 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Emil Pharmaceutical Industries.

Emil Pharmaceutical Industries Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 27.54% increase. The company also saw a substantial fall in profitability, with a 36.19% decrease in profit. The company's net worth Soared by an impressive increase of 138.92%.

Emil Pharmaceutical Industries revenue growth over time
Emil Pharmaceutical Industries profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 27.54%
*******
*******
*******
*******
Revenue from Operations
*******
 26.95%
*******
*******
*******
*******
Total Assets
*******
 193.59%
*******
*******
*******
*******
Profit or Loss
*******
 -36.19%
*******
*******
*******
*******
Net Worth
*******
 138.92%
*******
*******
*******
*******
EBITDA
*******
 -17.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Emil Pharmaceutical Industries?

In 2024, Emil Pharmaceutical Industries had a promoter holding of 74.09% and a public holding of 25.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,130,000,000.00

Satisfied Charges

₹884,579,000.00

Charges Breakdown by Lending Institutions
  • Others : 115.00 Cr
  • Hdfc Bank Limited : 53.00 Cr
  • Axis Bank Limited : 45.00 Cr
Latest Charge Details
Date Lender Amount Status
26 Jul 2024 Others ₹25.00 Cr Open
20 Apr 2024 Hdfc Bank Limited ₹53.00 Cr Open
12 Feb 2024 Others ₹7.00 Cr Open
12 Feb 2024 Others ₹33.00 Cr Open
19 Oct 2023 Axis Bank Limited ₹45.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Emil Pharmaceutical Industries?

Emil Pharmaceutical Industries has a workforce of 81 employees as of Mar 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Emil Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emil Pharmaceutical Industries's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Emil Pharmaceutical Industries
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 09 Sep 2020 via Charge ID 100408361 with Others was fully satisfied on 04 Jun 2025. was completed.

  • Charges

    A charge registered on 05 Aug 2016 via Charge ID 100061660 with Others was fully satisfied on 04 Jun 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 25.00 Cr registered on 26 Jul 2024 with Charge ID 100963643 was modified on 16 Jan 2025. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 53.00 Cr registered on 20 Apr 2024 with Charge ID 100906887 was modified on 16 Jan 2025. was documented.

  • Charges

    A charge with Others of Rs. 7.00 Cr registered on 12 Feb 2024 with Charge ID 100862176 was modified on 16 Jan 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 33.00 Cr registered on 12 Feb 2024 with Charge ID 100862168 was modified on 16 Jan 2025. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Emil Pharmaceutical Industries Private Limited?

The CIN of Emil Pharmaceutical Industries Private Limited is U24230MH1986PTC039809.

Where is Emil Pharmaceutical Industries Private Limited headquartered?

Emil Pharmaceutical Industries Private Limited is headquartered at 101 Mangalamkulupwadi Borivali E, Mumbai, Maharashtra, 400066.

When was Emil Pharmaceutical Industries Private Limited incorporated?

Emil Pharmaceutical Industries Private Limited was incorporated on 13 May 1986.

Who are the current directors of Emil Pharmaceutical Industries Private Limited?

The current directors of Emil Pharmaceutical Industries Private Limited are

What is the primary industry of Emil Pharmaceutical Industries Private Limited?

The primary industry of Emil Pharmaceutical Industries Private Limited is Manufacturing.

Is Emil Pharmaceutical Industries Private Limited a listed company?

Emil Pharmaceutical Industries Private Limited is unlisted.

What is the capital structure of Emil Pharmaceutical Industries Private Limited?

The authorized capital of Emil Pharmaceutical Industries Private Limited is ₹34.15 Cr, and the paid-up capital is ₹21.33 Cr.

What is the compliance status of Emil Pharmaceutical Industries Private Limited?

The compliance status of Emil Pharmaceutical Industries Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available